Pentraxin 3 and C-reactive protein in severe meningococcal disease

Shock

Volumn 31, Issue 1, 2009, Pages 28-32

  Sprong, Tom ^a,b   Peri, Giuseppe ^c   Neeleman, Chris ^b   Mantovani, Alberto ^c   Signorini, Stefano ^d   Van Der Meer, Jos W M ^a,b   Van Deuren, Marcel ^a,b  

^a Department of General Internal Medicine ^*  (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^d UNIVERSITY OF MILANO BICOCCA   (Italy)

Author keywords

C reactive protein; Cytokines; Endotoxin; Meningitis; Neisseria meningitidis; PTX3; Sepsis; Septic shock

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN; PENTRAXIN 3;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; BACTEREMIA; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIC MENINGITIS; FEMALE; FIBRINOGEN BLOOD LEVEL; HOSPITAL ADMISSION; HUMAN; INFANT; INTENSIVE CARE UNIT; LENGTH OF STAY; MALE; MENINGOCOCCEMIA; PROTEIN BLOOD LEVEL;

ADOLESCENT; ADULT; BACTEREMIA; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CHILD; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNITY, INNATE; INFANT; MALE; MENINGITIS, MENINGOCOCCAL; RETROSPECTIVE STUDIES; SERUM AMYLOID P-COMPONENT; SHOCK, SEPTIC;

EID: 58849092264     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/SHK.0b013e31817fd543     Document Type: Article

References (39)

1. Van Deuren M, Brandtzaeg P, Van der Meer JWM: Update on meningococcal disease with emphasis on pathogenesis and clinical management. Clin Microbiol Rev 13:144-166, 2000.
2. Sprong T, Pickkers P, Geurts-Moespot A, van der Ven-Jongekrijg J, Neeleman C, Knaup M, Leroy D, Calandra T, van der Meer JW, Sweep F, et al.: Macrophage migration inhibitory factor (MIF) in meningococcal septic shock and experimental human endotoxemia. Shock 27:482-487, 2007.
3. Pickkers P, Sprong T, Eijk L, Hoeven H, Smits P, Deuren M: Vascular endothelial growth factor is increased during the first 48 hours of human septic shock and correlates with vascular permeability. Shock 24:508-512, 2005.
4. Garlanda C, Bottazzi B, Bastone A, Mantovani A: Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility. Annu Rev Immunol 23:337-366, 2005.
5. Baumann H, Gauldie J: The acute phase response. Immunol Today 15:74-80, 1994.
6. Steel DM, Whitehead AS: The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein. Immunol Today 15:81-88, 1994.
7. Volanakis JE: Human C-reactive protein: expression, structure, and function. Mol Immunol 38:189-197, 2001.
8. Agrawal A: CRP after 2004. Mol Immunol 42:927-930, 2005.
9. Alles VV, Bottazzi B, Peri G, Golay J, Introna M, Mantovani A: Inducible expression of PTX3, a new member of the pentraxin family, in human mononuclear phagocytes. Blood 84:3483-3493, 1994.
10. Bottazzi B, Vouret-Craviari V, Bastone A, De Gioia L, Matteucci C, Peri G, Spreafico F, Pausa M, D'Ettorre C, Gianazza E, el al.: Multimer formation and ligand recognition by the long pentraxin PTX3. Similarities and differences with the short pentraxins C-reactive protein and serum amyloid P component. J Biol Chem 272:32817-32823, 1997.
11. Basile A, Sica A, d'Aniello E, Breviario F, Garrido G, Castellano M, Mantovani A, Introna M: Characterization of the promoter for the human long pentraxin PTX3. Role of NF-kappaB in tumor necrosis factor-alpha and interleukin-1 beta regulation. J Biol Chem 272:8172-8178, 1997.
12. Doni A, Michela M, Bottazzi B, Peri G, Valentino S, Polentarutti N, Garlanda C, Mantovani A: Regulation of PTX3, a key component of humoral innate immunity in human dendritic cells: stimulation by IL-10 and inhibition by IFN-gamma. J Leukoc Biol 79:797-802, 2006.
13. He X, Han B, Liu M: Long pentraxin 3 in pulmonary infection and acute lung injury. Am J Physiol Lung Cell Mol Physiol 292:L1039-L1049, 2007.
14. Muller B, Peri G, Doni A, Torri V, Landmann R, Bottazzi B, Mantovani A: Circulating levels of the long pentraxin PTX3 correlate with severity of infection in critically ill patients. Cril Care Med 29:1404-1407, 2001.
15. Mairuhu AT, Peri G, Setiati TE, Hack CE, Koraka P, Soemantri A, Osterhaus AD, Brandjes DP, van der Meer JW, Mantovani A, et al.: Elevated plasma levels of the long pentraxin, pentraxin 3, in severe dengue virus infections. J Med Virol 76:547-552, 2005.
16. Fazzini F, Peri G, Doni A, Dell'Antonio G, Dal Cin E, Bozzolo E, D'Auria F, Praderio L, Ciboddo G, Sabbadini MG, et al.: PTX3 in small-vessel vasculitides: an independent indicator of disease activity produced at sites of inflammation. Arthritis Rheum 44:2841-2850, 2001.
17. Casado-Flores J, Blanco-Quiros A, Nieto M, Asensio J, Fernandez C: Prognostic utility of the semi-quantitative procalcitonin test, neutrophil count and C-reactive protein in meningococcal infection in children. Eur J Pediatr 165:26-29, 2006.
18. Van der Kaay DC, De Kleijn ED, De Rijke YB, Hop WC, De Groot R, Hazelzet JA: Procalcitonin as a prognostic marker in meningococcal disease. Intensive Care Med 28:1606-1612, 2002.
19. Kuppermann N, Malley R, Inkelis SH, Fleisher GR: Clinical and hematologic features do not reliably identify children with unsuspected meningococcal disease. Pediatrics 103:E20, 1999.
20. Hsiao AL, Baker MD: Fever in the new millennium: a review of recent studies of markers of serious bacterial infection in febrile children. Curr Opin Pediatr 17:56-61, 2005.
21. Mantovani AGC, Doni A, Bottazzi B: Pentraxins in innate immunity: from Creactive protein to the long pentraxin PTX3. J Clin Immunol 28:1-13, 2008.
22. Peri G, Introna M, Corradi D, Iacuitti G, Signorini S, Avanzini F, Pizzetti F, Maggioni AP, Moccetti T, Metra M, et al.: PTX3, a prototypical long pentraxin, is an early indicator of acute myocardial infarction in humans. Circulation 102:636-641, 2000.
23. Pollack MM, Ruttimann UE, Getson PR: Pediatric risk of mortality (PRISM) score. Crit Care Med 16:1110-1116, 1988.
24. van Brakel MJ, van Vught AJ, Gemke RJ: Pediatric risk of mortality (PRISM) score in meningococcal disease. Eur J Pediatr 159:232-236, 2000.
25. Lee GW, Goodman AR, Lee TH, Vilcelc J: Relationship of TSG-14 protein to the pentraxin family of major acute phase proteins. J Immunol 153: 3700-3707, 1994.
26. Introna M, Alles VV, Castellano M, Picardi G, De Gioia L, Bottazzai B. Peri G, Breviario F, Salmona M, De Gregorio L, et al.: Cloning of mouse ptx3, a new member of the pentraxin gene family expressed at extrahepatic sites. Blood 87:1862-1872, 1996.
27. Kalil AC, Coyle SM, Urn JY, LaRosa SP, Turlo MA. Calvano SE. Sundin DP. Nelson DR. Lowry SF: Effects of drotrecogin alfa (activated) in human endotoxemia. Shock 21:222-229, 2004.
28. Derhaschnig U, Bergmair D, Marsik C. Schlifke I, Wijdenes J, Jilma B: Effect of interleukin-6 blockade on tissue factor-induced coagulation in human endotoxemia. Crit Care Med 32:1136-1140, 2004.
29. Kvalsvig AJ, Unsworth DJ: The immunopathogenesis of meningococcal disease. J Clin Pathol 56:417-422, 2003.
30. Moller AS, Bjerre A, Brusletto B, Joo GB, Brandtzaeg P, Kierulf P: Chemokine patterns in meningococcal disease. J Infect Dis 191:768-775, 2005.
31. van Eijk LT. Pickkers P, Smits P, van den Broek W, Bouw MP, van der Hoeven JG: Microvascular permeability during experimental human endotoxemia: an open intervention study. Crit Care 9:R157-R164, 2005.
32. Neeleman C, van Deuren M, van der Meer JWM: Acute meningokokkeninfecties: lage C-reactief proteïne (CRP)-concentratie in het serum bij opname wijst op een fulminant beloop. Tijdschr Kindergeneeskd 66:107-110, 1998.
33. Marzouk O, Bestwick K, Thomson AP, Sills JA. Hart CA: Variation in serum C-reactive protein across the clinical spectrum of meningococcal disease. Acta Paediatr 82:729-733, 1993.
34. Van Deuren M, van der Ven Jongekrijg J, Bartelink AKM, van Dalen R. Sauerwein RW, van der Meer JWM: Correlation between proinflammatory cytokines and antiinflammatory mediators and the severity of disease in meningococcal infections. J Infect Dis 172:433-439, 1995.
35. Brandtzaeg P, Kierulf P, Gaustad P, Skulberg A, Bruun JN, Halvorsen S. Sørensen E: Plasma endotoxin as a predictor of multiple organ failure and death in systemic meningococcal disease. J Infect Dis 159:195-204. 1989.
36. 36.Waage A, Halstensen A, Espevik T: Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease. Lancet 1:355-357, 1987.
37. Napoleone E, di Santo A, Peri G, Mantovani A, de Gaetano G, Donati MB, Lorenzet R: The long pentraxin PTX3 up-regulates tissue factor in activated monocytes: another link between inflammation and clotting activation. J Leukoc Biol 76:203-209. 2004.
38. Napoleone E, Di Santo A, Bastone A, Peri G, Mantovani A, de Gaetano G, Donati MB, Lorenzet R: Long pentraxin PTX3 upregulates tissue factor expression in human endothelial cells: a novel link between vascular inflammation and clotting activation. Arterioscler Thromh Vase Biol 22:782-787, 2002.
39. Jeannin P, Bottazzi B, Sironi M, Doni A, Rusnati M, Presta M, Maina V, Magistrelli G, Haeuw JF, Hoeffel G, et al.: Complexity and complementarity of outer membrane protein A recognition by cellular and humoral innate immunity receptors. Immunity 22:551-560, 2005.